347 related articles for article (PubMed ID: 16616323)
1. Prophylaxis in rare coagulation disorders -- factor XIII deficiency.
Nugent DJ
Thromb Res; 2006; 118 Suppl 1():S23-8. PubMed ID: 16616323
[TBL] [Abstract][Full Text] [Related]
2. Factor XIII Deficiency.
Karimi M; Bereczky Z; Cohan N; Muszbek L
Semin Thromb Hemost; 2009 Jun; 35(4):426-38. PubMed ID: 19598071
[TBL] [Abstract][Full Text] [Related]
3. Factor XIII deficiency.
Hsieh L; Nugent D
Haemophilia; 2008 Nov; 14(6):1190-200. PubMed ID: 19141159
[TBL] [Abstract][Full Text] [Related]
4. Corifact™/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study.
Nugent D
Thromb Res; 2012 Dec; 130 Suppl 2():S12-4. PubMed ID: 23439001
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
Ashley C; Chang E; Davis J; Mangione A; Frame V; Nugent DJ
Haemophilia; 2015 Jan; 21(1):102-8. PubMed ID: 25377187
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and safety of plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
Nugent DJ; Ashley C; García-Talavera J; Lo LC; Mehdi AS; Mangione A
Haemophilia; 2015 Jan; 21(1):95-101. PubMed ID: 25458735
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis in rare coagulation disorders -- factor X deficiency.
Auerswald G
Thromb Res; 2006; 118 Suppl 1():S29-31. PubMed ID: 16574201
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of a novel mutation in the factor XIII a subunit gene associated with a severe defect: importance of prophylactic substitution.
Morange P; Trigui N; Frère C; Chambost H; Pouymayou C; Uters M; Boucly C; Juhan-Vague I; de Mazancourt P
Blood Coagul Fibrinolysis; 2009 Oct; 20(7):605-6. PubMed ID: 19713833
[TBL] [Abstract][Full Text] [Related]
9. Long-term prophylaxis in patients with severe congenital factor XIII deficiency is not complicated by inhibitor formation.
Naderi M; Ahmadinejad M; Hosseini MS; Moradi E; Dorgalaleh A; Shamsizadeh M
Blood Coagul Fibrinolysis; 2017 Jun; 28(4):276-278. PubMed ID: 27306330
[TBL] [Abstract][Full Text] [Related]
10. Biology of Factor XIII and clinical manifestations of Factor XIII deficiency.
Levy JH; Greenberg C
Transfusion; 2013 May; 53(5):1120-31. PubMed ID: 22928875
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with a pasteurised human plasma concentrate in factor XIII deficiency.
Daly HM; Haddon ME
Thromb Haemost; 1988 Apr; 59(2):171-4. PubMed ID: 3388293
[TBL] [Abstract][Full Text] [Related]
12. Developing the First Recombinant Factor XIII for Congenital Factor XIII Deficiency: Clinical Challenges and Successes.
Carcao M; Fukutake K; Inbal A; Kerlin B; Lassila R; Oldenburg J; Garly ML; Nugent D
Semin Thromb Hemost; 2017 Feb; 43(1):59-68. PubMed ID: 27556350
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic therapy with Fibrogammin P is associated with a decreased incidence of bleeding episodes: a retrospective study.
Lusher J; Pipe SW; Alexander S; Nugent D
Haemophilia; 2010 Mar; 16(2):316-21. PubMed ID: 20017752
[TBL] [Abstract][Full Text] [Related]
14. Acquired plasma factor XIII deficiencies.
Tosetto A; Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):5-10. PubMed ID: 8039759
[TBL] [Abstract][Full Text] [Related]
15. Reduced levels of coagulation factor XIII in patients with advanced tumor disease.
Born P; Lippl F; Ulm K; Gerein P; Lersch C; Eckel F; Fischer G; Sandschin W; Dlaska U; Classen M
Hepatogastroenterology; 2000; 47(31):194-8. PubMed ID: 10690608
[TBL] [Abstract][Full Text] [Related]
16. Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit.
Tahlan A; Ahluwalia J
Arch Pathol Lab Med; 2014 Feb; 138(2):278-81. PubMed ID: 24476525
[TBL] [Abstract][Full Text] [Related]
17. International registry on factor XIII deficiency: a basis formed mostly on European data.
Ivaskevicius V; Seitz R; Kohler HP; Schroeder V; Muszbek L; Ariens RA; Seifried E; Oldenburg J;
Thromb Haemost; 2007 Jun; 97(6):914-21. PubMed ID: 17549292
[TBL] [Abstract][Full Text] [Related]
18. Alloantibodies against the B subunit of plasma factor XIII developed in its congenital deficiency.
Wada H; Souri M; Matsumoto R; Sugihara T; Ichinose A
Thromb Haemost; 2013 Apr; 109(4):661-8. PubMed ID: 23407795
[TBL] [Abstract][Full Text] [Related]
19. Minimal factor XIII activity level to prevent major spontaneous bleeds.
Menegatti M; Palla R; Boscarino M; Bucciarelli P; Muszbek L; Katona E; Makris M; Peyvandi F;
J Thromb Haemost; 2017 Sep; 15(9):1728-1736. PubMed ID: 28688221
[TBL] [Abstract][Full Text] [Related]
20. [Congenital factor XIII deficiency required high-dose factor XIII concentrate in late pregnancy].
Takahashi T; Hatao K; Suzukawa M; Oji T
Rinsho Ketsueki; 2007 May; 48(5):418-20. PubMed ID: 17571589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
